Blood–retinal barrier in hypoxic ischaemic conditions: Basic concepts, clinical features and management

This publication has 66 references indexed in Scilit:

• A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular Edema
  Ophthalmology, 2008
• A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular Edema
  Ophthalmology, 2007
• Pegaptanib 1-Year Systemic Safety Results from a Safety–Pharmacokinetic Trial in Patients with Neovascular Age-Related Macular Degeneration
  Ophthalmology, 2007
• Hypoxia Disrupts the Barrier Function of Neural Blood Vessels through Changes in the Expression of Claudin-5 in Endothelial Cells
  The American Journal of Pathology, 2007
• TNF-α is critical for ischemia-induced leukostasis, but not retinal neovascularization nor VEGF-induced leakage
  Journal of Neuroimmunology, 2006
• Year 2 Efficacy Results of 2 Randomized Controlled Clinical Trials of Pegaptanib for Neovascular Age-Related Macular Degeneration
  Ophthalmology, 2006
• The molecular regulation of organelle transport in mammalian retinal pigment epithelial cells
  Pigment Cell Research, 2006
• A central role for inflammation in the pathogenesis of diabetic retinopathy
  The FASEB Journal, 2004
• Cultured retinal neuronal cells and Müller cells both show net production of lactate
  Neurochemistry International, 2004
• Nitric oxide mediates hypoxia-induced changes in paracellular permeability of cerebral microvasculature
  American Journal of Physiology-Heart and Circulatory Physiology, 2004